Documents › 3a0160e9792366039c4c24908c2d7e1cb47c0353:1-73

NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users

POST board policyreference 2022-12 73 pages (file pages 1–73) original file
About this document
Layer
attachment: a document a meeting packet links to
Type as titled
publication (kind from doc_type)
File
3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
Cases
POST 2313715 · Jaime Bermudez (filed under case)

About: Jaime Bermudez (case)

Page 15 · file page 15 larger image
Image of page 15; its text is alongside
Text: OCR

THC initially appeared to be associated with higher odds of being involved in a crash, but after driver age and sex were taken into consideration no increase in risk could be associated with the presence of THC in a driver's system. The study did not include information on drug prevalence among other roadway users (pedestrians, bicyclists, passengers) involved in crashes.

Only one study has attempted to estimate the risk associated with alcohol and other drug use by drivers involved in serious injury or fatal crashes (Hels et al., 2011). This large-scale European study found that drugs other than alcohol could potentially increase the risk of being seriously injured in a crash, but the study did not test for as many drugs as the Virginia Beach study and had some methodological issues inherent in this type and scale of research being conducted at several sites. A study conducted in Canada examined the prevalence of alcohol and a variety of other potentially impairing drugs among injured drivers who arrived for treatment at an emergency department within 6 hours of a crash during 2018 to 2021 (Brubacher et al., 2021). De-identified study samples ( $N = 4,976$ ) were obtained under a waiver of consent when a physician had already ordered blood for clinical/treatment purposes. Overall, 50.8% of the drivers tested positive for at least one drug included on the study's toxicology panel. Alcohol (15.5%) and cannabis (active THC, 18.8%) were the most prevalent individual drugs while 10.9% tested positive for other recreational drugs (e.g., cocaine, amphetamines), and 20.7% tested positive for some type of sedating medication as classified by the study. The study did not include any roadway users other than drivers.

The above studies provided substantial insights into drugged driving, but a knowledge gap exists regarding drug use among drivers and other road users (e.g., pedestrians, bicyclists) who are seriously or fatally injured in crashes in the United States. Part of this gap is due to inconsistencies in how drug data are collected by States and reported to NHTSA for entry into its Fatality Analysis Reporting System (FARS). As noted by Berning and Smither (2014) and Berning et al. (2022), State drug testing and reporting policies and procedures vary widely for individuals involved in fatal crashes substantially limiting FARS' usefulness for understanding the role drugs could be playing in fatal crashes. The current study sought to fill these gaps by examining drug prevalence among a large sample of seriously injured drivers and other crash victims presenting to selected trauma centers, and fatally injured crash victims presenting directly to medical examiners (MEs) at selected sites.3

Shortly after this project began, however, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections started a pandemic of respiratory disease (commonly referred to as COVID-19). A public health emergency was declared on March 13, 2020 (White House, 2020). Notable changes in travel patterns and driver behaviors were documented in special reports released by NHTSA (Wagner et al., 2020; Office of Behavioral Safety Research, 2021a, 2021b). These reports indicated Americans were driving less early in the public health emergency. However, those who remained on the roads engaged in riskier behaviors, including speeding and failure to wear seat belts, which may have contributed to the substantial increases in observed fatality rates (Office of Behavioral Safety Research, 2021a). This study's protocols were revised to meet new restrictions on research at the selected trauma centers and to process samples to allow the National Institutes of Health (NIH) to conduct serological testing of collected samples for COVID-19 antibodies as part of a separate, but coordinated, research effort


3 A person pronounced dead at the scene of a crash is often taken directly to the ME or coroner's office, but not always. Some of the trauma center cases included this study may have died at the scene but were still transported to the hospital, died during transport, or succumbed to their injuries at a later date.

7

Keys: ← → or j k turn pages; / finds.